Abstract
Renal angiomyolipomas (AMLs) are benign renal masses that are often asymptomatic and detected incidentally. However, treatment might be necessary in symptomatic presentations or when the mass exceeds 4 cm in size. While the goal of management for renal AMLs is to relieve symptoms and prevent hemorrhage, a priority is renal function preservation, especially given the propensity of these lesions to recur. The traditional treatment for renal AMLs is renal angioembolization or surgical excision of the lesion. With advancements in minimally invasive surgery, several other modalities have now emerged for nephron sparing approaches. These include angioembolization, laparoscopic and percutaneous ablative therapies such as radiofrequency ablation, cryoablation and microwave ablation, and pure or robot-assisted laparoscopic partial nephrectomy. Given the relatively low frequency of renal AMLs requiring treatment, much of the available literature on these minimally invasive approaches is largely extrapolative, based on series on small renal masses, i.e. renal cell carcinoma (RCC). This report is based on a thorough review of the published literature to date on the minimally invasive treatment and outcomes of renal AMLs.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •Of importance
Stillwell TJ, Gomez MR, Kelalis PP. Renal lesions in tuberous sclerosis. J Urol. 1987;138(3):477–81.
Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol. 2002;168(4 Pt 1):1315–25.
Bissler JJ, Kingswood JC. Renal angiomyolipomata. Kidney Int. 2004;66(3):924–34.
Lemaitre L, Claudon M, Dubrulle F, Mazeman E. Imaging of angiomyolipomas. Semin Ultrasound CT MR. 1997;18(2):100–14.
Seyam RM, Bissada NK, Kattan SA, et al. Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms. Urology. 2008;72(5):1077–82.
Dickinson M, Ruckle H, Beaghler M, Hadley HR. Renal angiomyolipoma: optimal treatment based on size and symptoms. Clin Nephrol. 1998;49(5):281–6.
Oesterling JE, Fishman EK, Goldman SM, Marshall FF. The management of renal angiomyolipoma. J Urol. 1986;135(6):1121–4.
Fazeli-Matin S, Novick AC. Nephron-sparing surgery for renal angiomyolipoma. Urology. 1998;52(4):577–83.
Han YM, Kim JK, Roh BS, et al. Renal angiomyolipoma: selective arterial embolization—effectiveness and changes in angiomyogenic components in long-term follow-up. Radiology. 1997;204(1):65–70.
• Kothary N, Soulen MC, Clark TW, et al. Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol. 2005;16(1):45–50. One of the longest term follow-up data post-RAE for AMLs. The authors underscore the significance of life-long surveillance for recurrences of AMLs in patients with tuberous sclerosis.
Lenton J, Kessel D, Watkinson AF. Embolization of renal angiomyolipoma: immediate complications and long-term outcomes. Clin Radiol. 2008;63(8):864–70.
Villalta JD, Sorensen MD, Durack JC, Kerlan RK, Stoller ML. Selective arterial embolization of angiomyolipomas: a comparison of smaller and larger embolic agents. J Urol. 2011;186(3):921–7.
Hamlin JA, Smith DC, Taylor FC, McKinney JM, Ruckle HC, Hadley HR. Renal angiomyolipomas: long-term follow-up of embolization for acute hemorrhage. Can Assoc Radiol J. 1997;48(3):191–8.
• Bishay VL, Crino PB, Wein AJ, et al. Embolization of giant renal angiomyolipomas: technique and results. J Vasc Interv Radiol. 2010;21(1):67–72. This paper reviews the prophylactic treatment of 23 large AMLs (> 10 cm) with renal angioembolization alone, while preserving renal function. This highlights the unique applicability of RAE in the management of very large AMLs, while achieving the goal of renal function preservation.
Prevoo W, van den Bosch MA, Horenblas S. Radiofrequency ablation for treatment of sporadic angiomyolipoma. Urology. 2008;72(1):188–91.
Jacomides L, Ogan K, Watumull L, Cadeddu JA. Laparoscopic application of radio frequency energy enables in situ renal tumor ablation and partial nephrectomy. J Urol. 2003;169(1):49–53. discussion 53.
Sooriakumaran P, Gibbs P, Coughlin G, et al. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int. 2010;105(1):101–6.
• Castle SM, Gorbatiy V, Ekwenna O, Young E, Leveillee RJ. Radiofrequency ablation (RFA) therapy for renal angiomyolipoma (AML): an alternative to angio-embolization and nephron-sparing surgery. BJU Int. 2012;109(3):384–7. The authors review the largest series on radiofrequency ablation of renal AMLs.
Delworth MG, Pisters LL, Fornage BD, von Eschenbach AC. Cryotherapy for renal cell carcinoma and angiomyolipoma. J Urol. 1996;155(1):252–4. discussion 254–255.
Remer EM, Weinberg EJ, Oto A, O’Malley CM, Gill IS. MR imaging of the kidneys after laparoscopic cryoablation. AJR Am J Roentgenol. 2000;174(3):635–40.
Byrd GF, Lawatsch EJ, Mesrobian HG, Begun F, Langenstroer P. Laparoscopic cryoablation of renal angiomyolipoma. J Urol. 2006;176(4 Pt 1):1512–6. discussion 1516.
Johnson SC, Graham S, D’Agostino H, Elmajian DA, Shingleton WB. Percutaneous renal cryoablation of angiomyolipomas in patients with solitary kidneys. Urology. 2009;74(6):1246–9.
Wen CC, Nakada SY. Energy ablative techniques for treatment of small renal tumors. Curr Opin Urol. 2006;16(5):321–6.
Laeseke PF, Lee FT, Sampson LA, van der Weide DW, Brace CL. Microwave ablation versus radiofrequency ablation in the kidney: high-power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes. J Vasc Interv Radiol. 2009;20(9):1224–9.
Guan W, Bai J, Liu J, et al. Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results. J Surg Oncol. 2012;106(3):316–21.
• Msezane L, Chang A, Shikanov S, et al. Laparoscopic nephron-sparing surgery in the management of angiomyolipoma: a single center experience. J Endourol. 2010;24(4):583–7. The authors contend that pre-operative imaging has poor postive predictive value and low sensitivity in diagnosing AMLs.
Simmons MN, Chung BI, Gill IS. Perioperative efficacy of laparoscopic partial nephrectomy for tumors larger than 4 cm. Eur Urol. 2009;55(1):199–207.
Lane BR, Aydin H, Danforth TL, et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol. 2008;180(3):836–43.
Schips L, Berardinelli F, Neri F, Tamburro FR, Cindolo L. Laparoendoscopic single-site partial nephrectomy without ischemia for very small, exophytic renal masses: surgical details and functional outcomes. Eur Urol. 2012. doi:10.1016/j.eururo.2012.08.008
Bolufer E, López-Fontana G, Castillo OA. Robot assisted partial nephrectomy (Da Vinci) in an angiomyolipoma associated to Wünderlich Syndrome. Arch Esp Urol. 2012;65(9):831–4.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sivalingam, S., Nakada, S.Y. Contemporary Minimally Invasive Treatment Options for Renal Angiomyolipomas. Curr Urol Rep 14, 147–153 (2013). https://doi.org/10.1007/s11934-013-0311-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11934-013-0311-3